Stefan Leucht
Technische Universität München
H-index: 122
Europe-Germany
Top articles of Stefan Leucht
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data | Spyridon Siafis Virginia Chiocchia Malcolm R Macleod Charlotte Austin Ava Homiar | 2024/4/11 | |
Cognitive behavioural therapy without medication for schizophrenia | Irene Bighelli Oğulcan Çıray Stefan Leucht | 2022 | |
Comparative efficacy and acceptability of treatment strategies for antipsychotic-induced akathisia: a systematic review and network meta-analysis | Yuki Furukawa Kota Imai Yusuke Takahashi Orestis Efthimiou Stefan Leucht | 2024 | |
Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders–An individual patient data meta-analysis | Brain, Behavior, and Immunity | Mattia Campana Vladislav Yakimov Joanna Moussiopoulou Isabel Maurus Lisa Löhrs | 2024/4/10 |
Antipsychotics for antipsychotic‐naïve people with psychosis | Hui Wu Angelika Burschinski Johannes Schneider-Thoma Stefan Leucht Spyridon Siafis | 2024 | |
Schizophrenien und andere primäre psychotische Störungen | Stefan Leucht Alkomiet Hasan Markus Jäger Ludger Tebartz van Elst Roland Vauth | 2024/1/1 | |
Sharing information across patient subgroups to draw conclusions from sparse treatment networks | Biometrical Journal | Theodoros Evrenoglou Silvia Metelli Johannes‐Schneider Thomas Spyridon Siafis Rebecca M Turner | 2024/4 |
Estimating the smallest worthwhile difference of antidepressants: a cross-sectional survey | BMJ Ment Health | Ethan Sahker Toshi A Furukawa Yan Luo Manuela L Ferreira Kaori Okazaki | 2024/1/1 |
Shortening the Alzheimer’s disease assessment scale cognitive subscale | European Psychiatry | Stephen Z Levine Yair Goldberg Anat Rotstein Myrto Samara Kazufumi Yoshida | 2024/1 |
Single-arm meta-analysis of drug response in placebo-controlled versus active-controlled antipsychotic drug trials in schizophrenia | Shimeng Dong Johannes Schneider-Thoma Spyridon Siafis Natalie Peter Stefan Leucht | 2024/7/1 | |
Development and Validation of a Machine Learning–Based Model of Mortality Risk in First-Episode Psychosis | Gastro Hep Advances | Ho Jung Choi Yeong Eun Kim Jung-Man Namgoong Inki Kim Jun Sung Park | 2023/1/1 |
Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test … | The Lancet Psychiatry | Spyridon Siafis Lasse Brandt Robert A McCutcheon Stefan Gutwinski Johannes Schneider-Thoma | 2024/1/1 |
Katatonie | Dusan Hirjak Ludger Tebartz van Elst Stefan Leucht Alkomiet Hasan | 2024/1/1 | |
Taking uncertainty in the assessment of response into account: An advanced guideline for computing responder rates in clinical trials. | European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology | Steffen Zitzmann Christoph Lindner Claudia Leucht Stefan Leucht | 2024/4/20 |
Are the results of open randomised controlled trials comparing antipsychotic drugs in schizophrenia biased? Exploratory meta-and subgroup analysis | Schizophrenia | Stefan Leucht Spyridon Siafis Johannes Schneider-Thoma Aran Tajika Josef Priller | 2024/2/15 |
Long-acting injectable second-generation antipsychotics vs placebo and their oral formulations in acute schizophrenia: A systematic review and meta-analysis of randomized … | Dongfang Wang Johannes Schneider-Thoma Spyridon Siafis Angelika Burschinski Shimeng Dong | 2024/1/1 | |
CHLORPROMAZINE (continued) | Prescriber's Guide: Stahl's Essential Psychopharmacology | CE Adams G Awad J Rathbone B Thornley U Ahmed | 2024/4/18 |
Understanding effect size: an international online survey among psychiatrists, psychologists, physicians from other medical specialities, dentists and other health professionals | BMJ Ment Health | Ferdinand Heimke Yuki Furukawa Spyridon Siafis Bradley C Johnston Rolf R Engel | 2024/1/1 |
Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data | The Lancet Psychiatry | Orestis Efthimiou Heidi Taipale Joaquim Radua Johannes Schneider-Thoma Justo Pinzón-Espinosa | 2024/2/1 |
A potential issue with PANSS responder analysis. | Schizophrenia Research | Steffen Zitzmann Christoph Lindner Claudia Leucht Stefan Leucht | 2023/10/23 |
